Erratum: Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer (British Journal of Cancer, (1998), 77, 11, (1806-1811), 10.1038/bjc.1998.300);Sticky and smelly issues: Lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 1806-1811

  Alexandroff, A B ^a   McIntyre, C A ^b   Porter, J C ^c   Zeuthen, J ^d   Vile, R G ^e   Taub, D D ^f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Apoptosis; Cell adhesion; Chemotaxis; Gene and adoptive cancer immunotherapy; Natural killer cells

Indexed keywords

CANCER VACCINE; CELL ADHESION MOLECULE; CHEMOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOPHENOL MONOOXYGENASE; TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; CANCER; CANCER IMMUNOTHERAPY; CELL ADHESION; CHEMOTAXIS; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; GENE THERAPY; HUMAN; LEUKOCYTE; METASTASIS; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR IMMUNOLOGY;

EID: 0031776984     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1998.484     Document Type: Erratum

References (31)

1. Alexandroff AB and Dalgleish AG (1997) Does theory still outstretch practice in cancer gene therapy? Mol Med Today 3: 524-527
2. Azuma M, Cayabyab M, Buck D, Phillips JH and Lanier LL (1992) Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol 149: 1115-1123
3. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP and Cheresh DA (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85: 683-693
4. Charpin C, Garcia S, Bouvier C, Martini F, Andrac L, Bonnier P, Lavaut MN and Allasia C (1997) CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up. Am J Clin Path 107: 534-541
5. Chen L, Chen D, Block E, O'Donnell M, Kufe DW and Clinton SK (1997) Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J Immunol 159: 351-359
6. Chong H and Vile RG (1996) New therapeutical approaches based on gene transfer techniques. Springer Semin Immunopathol 18: 149-170
7. DeGrendele HC, Estess P, Picker LJ and Siegelman MH (1996) CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 183: 1119-1130
8. Forni G and Foa R (1996) The role of cytokines in tumour rejection. In Tumour Immunology: Immunotherapy and Cancer Vaccines, Dalgleish AG and Browning M. (eds) pp. 199-218. Cambridge University Press: Cambridge
9. Giavazzi R, Foppolo M, Dossi R and Remuzzi A (1993) Rolling and adhesion of human tumour cells on vascular endothelium under physiological flow conditions. J Clin Invest 92: 3038-3044
10. Gong J, Chen D, Kashiwaba M and Kufe D ( 1997) Induction of antitumour activity by immunization with fusions of dendritic and carcinoma cells. Nature Med 3: 558-561
11. Kirkin AF, thor Straten P and Zeuthen J (1996) Differential modulation by IFN-γ of the sensitivity of human melanoma cells to cytolitic T cell clones which recognize differentiation or progression antigens. Cancer Immunol Immunother 42: 203-212
12. Knight BC, Souberbielle BE, Rizzardi GP, Ball SE and Dalgleish AG (1996) Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine. Melan Res 6: 299-306
13. Lanier LL and Phillips JH (1996) Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 17: 86-91
14. Lopez-Botet M, Moretta L and Strominger J (1996) NK-cell receptors and recognition of MHC class I molecules. Immunol Today 17: 212-214
15. Mackey MF, Gunn JR, Ting PP, Kikutani H, Dranoff G, Noelle RJ and Bath RJ Jr (1997) Protective immunity induced by tumour vaccines requires interaction between CD40 and its ligand, CD154. Cancer Res 57: 2569-2574
16. Matsuura N, Puzon-McLaughlin W, Irie A, Morikawa Y, Kakudo K and Takada Y (1996) Induction of experimental bone metastasis in mice by transfection of integrine α4β1 into tumour cells. Am J Pathol 148: 55-61
17. Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS and Moretta L (1996) Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA 93: 12433-12438
18. Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A and Moretta L (1997) IL-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol 27: 1374-1380
19. Preece G, Murphy G and Ager A (1996) Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem 271: 11634-11640
20. Qian F, Vaux DL and Weissman IL (1994) Expression of the integrin alpha 4 beta I on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77: 335-347
21. Ridge JP, Fuchs EJ and Matzinger P (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271: 1723-1726
22. Scholler J, Straten PT, Birck A, Siim E, Dahlstrom K, Drzewiecki KT and Zeuthen J (1994) Analysis of T cell receptor αβ variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions. Cancer Immunol Immunother 39: 239-248
23. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH and Galle PR (1997) Lymphocyte apoptosis induced by CD95 ligand-expressing tumour cells - a mechanism of immune evasion? Nature Med 2: 1361-1366
24. Szabo MC, Butcher EC, McIntyre BW, Schall TJ and Bacon KB (1997) RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3. Eur J Immunol 27: 1061-1068
25. Taub DD (1996) Chemokine-leukocyte interactions. The Voodoo that they do so well. Cytok Growth Fact Rev 7: 355-376
26. Taub DD and Oppenheim JJ (1994) Chemokines, inflammation and the immune system. Ther Immunol 1: 229-246
27. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL and Murphy WJ (1996a) Chemokines and T lymphocyte activation. J Immunol 156: 2095-2103
28. Taub DD, Ortaldo JR, Turcovski-Corrales SM, Key ML, Longo DL and Murphy WJ (1996b) β Chemokines costimulate lymphocyte cytolysts, proliferation, and lymphokine production. J Leuk Biol 59: 81-89
29. thor Straten P, Becker JC, Seremet T, Brocker EB and Zeuthen J (1996) Clonal T cell-responses in tumour infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J Clin Invest 98: 279-284
30. Walker PR, Saas P and Dietrich P-Y (1997) Commentary: role of Fas ligand in immune escape: the tumour cell strikes back. J Immunol 158: 4521-4524
31. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV and Chapman HA (1996) Regulation of integrin function by the urokinase receptor. Science 273: 1551-1555